Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings

Europace

6 Ottobre Ott 2020 16 days ago
  • Tondo C

The aim of the study was to describe ECG modifications and arrhythmic events in COVID-19 patients undergoing hydroxychloroquine (HCQ) therapy in different clinical settings.

Reference

Gasperetti A, Biffi M, Duru F, Schiavone M, Ziacchi M, Mitacchione G, Lavalle C, Saguner A, Lanfranchi A, Casalini G, Tocci M, Fabbricatore D, Salghetti F, Mariani MV, Busana M, Bellia A, Cogliati CB, Viale P, Antinori S, Galli M, Galiè N, Tondo C, Forleo GB. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings. Europace 2020 Sep 24;euaa216. doi: 10.1093/europace/euaa216

Go to PubMed